Skip to content
Robopedics logo — We are reinventing orthopedics. We make robots. We are ROBOP...

Robopedics

We are reinventing orthopedics. We make robots. We are ROBOPEDICS.

Founded 2021 Spain Spain 9 employees Equity Crowdfunding Health Care, Robotics

General Information

Company Name Robopedics
Founded Year 2021
Location Spain Spain
Employees 9
Industries Health Care, Robotics
Funding Stage Equity Crowdfunding
Social

BounceWatch is an independent company data service, not affiliated with Robopedics. To contact Robopedics, visit robopedics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Robopedics compare?

A PDF of Robopedics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Robopedics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Robopedics

Robopedics is a Spanish startup founded in 2021 with a mission to revolutionize orthopedics through robotics. Their slogan "We are reinventing orthopedics. We make robots. We are ROBOPEDICS" encapsulates their dedication to innovation in healthcare and robotics. The company aims to democratize access to advanced technology, allowing stroke-disabled individuals in wheelchairs to stand up and walk again at home, without medical supervision, thereby enhancing their quality of life.

Specializing in the Health Care and Robotics industries, Robopedics is focused on leveraging technology to bring about tangible improvements in the lives of individuals facing physical challenges. While details regarding their most recent investment are not available, the potential for combining cutting-edge robotics with healthcare underscores the viability and relevance of Robopedics in today's market.

As a venture capitalist, it's crucial to monitor the evolution and reception of Robopedics' technologies within the healthcare ecosystem, considering the potential for impactful advancements in rehabilitation and patient care. Additionally, keeping an eye on their expansion and partnerships within the healthcare sector will be key to evaluating their future growth prospects and potential avenues for investment.

No funding data available for Robopedics yet.

Robopedics Alternatives & Competitors

View All Alternatives
Robopedics vs
REEV
REEV United States

Building the future of walking assistance 🦿

Seed
39 employees
Health Care, Medical Devices
Robopedics vs
BIOMOTUM, Inc.
BIOMOTUM, Inc. United States

Transforming the treatment of impaired mobility by energizing every step.

Seed
12 employees
Health Care, Medical Devices
Robopedics vs
Abingdon Health plc
Abingdon Health plc United Kingdom

Improving life by making rapid results accessible to all. Lateral flow test development, manufacture...

Post-IPO Equity
73 employees
Biotechnology, Health Care

FAQ About Robopedics

We are reinventing orthopedics. We make robots. We are ROBOPEDICS.
Robopedics was founded in 2021.
Robopedics is headquartered in Spain.
Robopedics operates in Health Care and Robotics.
Robopedics has approximately 9 employees.
Top alternatives and competitors to Robopedics include REEV, BIOMOTUM, Inc., Abingdon Health plc, Wandercraft, UniExo Rehab. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Robopedics and REEV are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Robopedics, https://bouncewatch.com/company/robopedics, updated 3 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout